Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Biology and Evolution|May 19, 2012
Molecular signatures of the three stem cell lineages in hydra and the emergence of stem cell function at the base of multicellularityGeorg Hemmrich, Konstantin Khalturin, Anna-Marei Boehm, et al.
Neurology|July 22, 2016
Neuromuscular endplate pathology in recessive desminopathies: Lessons from man and miceHacer Durmuş, Özgecan Ayhan, Sebahattin Çırak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2013
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencingAndreas Keller, Petra Leidinger, Florian Steinmeyer, et al.
Developmental and Comparative Immunology|November 18, 2008
Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defenceThomas C G Bosch, René Augustin, Friederike Anton-Erxleben, et al.
Oncotarget|April 14, 2017
MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencingUgne Gyvyte, Simonas Juzenas, Violeta Salteniene, et al.
Nucleic Acids Research|September 12, 2012
From next-generation sequencing alignments to accurate comparison and validation of single-nucleotide variants: the pibase softwareMichael Forster, Peter Forster, Abdou Elsharawy, et al.
Current Biology : CB|January 21, 2014
Regulation of polyp-to-jellyfish transition in Aurelia auritaBjörn Fuchs, Wei Wang, Simon Graspeuntner, et al.
Journal of Crohn'S & Colitis|January 13, 2022
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel DiseaseSimonas Juzenas, Matthias Hübenthal, Carl Mårten Lindqvist, et al.
Hepatology Communications|July 5, 2024
Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitisMarit M Grimsrud, Michael Forster, Benjamin Goeppert, et al.
Oncotarget|September 8, 2018
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissueMichael Forster, Adam Mark, Friederike Egberts, et al.
Pageof 5